Rep. Frey Attends Legislative Open House at Boehringer Ingelheim in Ridgefield

(From Left to Right) State Rep. Joesph Taborsak, State Rep. Dan Carter, Boehringer Ingelheim CEO Paul Fonteyne, State Rep. John Frey, Ridgefield First Selectman Rudy Marconi

State Representative John Frey joined other state and municipal officials today to meet with the new President and CEO, Paul Fonteyne, and other members of the Boehringer Ingelheim leadership team during a Legislative Open House at the Boehringer Ingelheim Headquarters in Ridgefield.
 
During the meeting, state officials and company executives discussed issues pertaining to taxes, business regulations and deliberated on new, inventive ways to provide patients with better access to quality medication.
 
“Boehringer Ingelheim has been a staple in the Ridgefield community for years,” said Rep. Frey. “The campus in Ridgefield and Danbury provides employment for over 2,500 people who live throughout the region.  I will do all I can to ensure that Boehringer Ingelheim has the support they need from the legislature to keep their business growing successfully.”
 
At the meeting Rep. Frey reflected back to when Boehringer Ingelheim first came to Ridgefield in the 1970′s, using the old high school on East Ridge as their headquaters with 120 employees.  Now, they have a growing, sprawling campus with a deeper commitment to our region.
 
A few of the issues raised by Boehringer Ingelheim included the consternation last years’ retroactive income tax increase had on employees, education needs of future hires and the need to provide a stable tax and regulation structure in Connecticut.
 
Boehringer Ingelheim Pharmaceuticals, Inc. is the largest U.S. subsidiary of Boehringer Ingelheim Corporation.
The 125 year-old family-owned company focuses primarily on researching and developing treatments for several different types of diseases.
 
While currently researching to treat more than 22 chronic conditions, the corporation has successfully launched more than a dozen major products that have advanced healthcare treatment in the past decade.
 
Layout Image